371 related articles for article (PubMed ID: 29774396)
21. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
Lok BH; Setton J; Caria N; Romanyshyn J; Wolden SL; Zelefsky MJ; Park J; Rowan N; Sherman EJ; Fury MG; Ho A; Pfister DG; Wong RJ; Shah JP; Kraus DH; Zhang Z; Schupak KD; Gelblum DY; Rao SD; Lee NY
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1851-7. PubMed ID: 21640497
[TBL] [Abstract][Full Text] [Related]
23. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.
Panje C; Riesterer O; Glanzmann C; Studer G
BMC Cancer; 2017 Sep; 17(1):643. PubMed ID: 28893236
[TBL] [Abstract][Full Text] [Related]
25. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
27. Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients.
Verma V; Liu J; Eschen L; Danieley J; Spencer C; Lewis JS; Diaz J; Piccirillo JF; Adkins DR; Nussenbaum B; Thorstad WL; Gay HA
Radiat Oncol; 2015 Jan; 10():8. PubMed ID: 25572866
[TBL] [Abstract][Full Text] [Related]
28. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
29. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
30. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
31. Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.
Davis KS; Lim CM; Clump DA; Heron DE; Ohr JP; Kim S; Duvvuri U; Johnson JT; Ferris RL
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1613-7. PubMed ID: 26681273
[TBL] [Abstract][Full Text] [Related]
32. Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior.
Alexiev BA; Obeidin F; Johnson DN; Finkelman BS; Prince R; Somani SN; Cheng E; Samant S
Pathol Res Pract; 2020 Dec; 216(12):153243. PubMed ID: 33113454
[TBL] [Abstract][Full Text] [Related]
33. Differences in geometric patterns of failure in human papillomavirus (HPV)-associated and HPV-non-associated oropharyngeal cancer after definitive radiotherapy.
Yuvnik T; Chia L; Laura OC; Tieu TT; Mahesh K; Bradley B; Daron C; Chris W
Head Neck; 2024 Mar; 46(3):552-560. PubMed ID: 38108534
[TBL] [Abstract][Full Text] [Related]
34. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
[TBL] [Abstract][Full Text] [Related]
36. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
[TBL] [Abstract][Full Text] [Related]
37. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
[TBL] [Abstract][Full Text] [Related]
38. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
[TBL] [Abstract][Full Text] [Related]
39. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
[TBL] [Abstract][Full Text] [Related]
40. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
Adrian G; Carlsson H; Kjellén E; Sjövall J; Zackrisson B; Nilsson P; Gebre-Medhin M
Radiat Oncol; 2022 Jun; 17(1):107. PubMed ID: 35701827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
